Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells.
about
Pluronic(®) P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells.Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro.Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery.Biomacromolecule/lipid hybrid nanoparticles for controlled delivery of sorafenib in targeting hepatocellular carcinoma therapy.Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs
P2860
Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Lipid nanocarriers containing ...... n human hepatocarcinoma cells.
@en
type
label
Lipid nanocarriers containing ...... n human hepatocarcinoma cells.
@en
prefLabel
Lipid nanocarriers containing ...... n human hepatocarcinoma cells.
@en
P2093
P1476
Lipid nanocarriers containing ...... n human hepatocarcinoma cells.
@en
P2093
Chiara Botto
Emanuela Fabiola Craparo
Erika Amore
Giuseppa Augello
Maria Luisa Bondì
Maria Rita Emma
P356
10.1016/J.IJPHARM.2015.07.055
P407
P577
2015-07-23T00:00:00Z